Evaluating the immune status of tumor microenvironments
Core D: Pathology and BioImaging
['FUNDING_P01'] · ROSWELL PARK CANCER INSTITUTE CORP · NIH-10916171
This study is looking at how tumors interact with the immune system to help us learn more about how they behave and how well different treatments might work for patients like you.
Quick facts
| Phase | ['FUNDING_P01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | ROSWELL PARK CANCER INSTITUTE CORP (nih funded) |
| Locations | 1 site (BUFFALO, UNITED STATES) |
| Trial ID | NIH-10916171 on ClinicalTrials.gov |
What this research studies
This research focuses on assessing the immune environment surrounding tumors to better understand how they interact with the body's immune system. It utilizes advanced techniques for immune profiling, cell and tissue analysis, and imaging to collect and analyze tumor samples. Patients' tumor specimens will be processed to evaluate various immune markers and genetic information, which may provide insights into the effectiveness of treatments. The goal is to enhance the understanding of tumor behavior and patient responses to therapies.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients undergoing treatment for cancer who are willing to provide tumor samples for analysis.
Not a fit: Patients with non-cancerous conditions or those not undergoing any form of cancer treatment may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved treatment strategies tailored to individual patients based on their tumor's immune characteristics.
How similar studies have performed: Other research has shown promising results in utilizing immune profiling to inform cancer treatment strategies, indicating that this approach has potential for success.
Where this research is happening
BUFFALO, UNITED STATES
- ROSWELL PARK CANCER INSTITUTE CORP — BUFFALO, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: BSHARA, WIAM — ROSWELL PARK CANCER INSTITUTE CORP
- Study coordinator: BSHARA, WIAM
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.